Previous Close | 7.50 |
Open | 9.35 |
Bid | 8.60 |
Ask | 8.80 |
Strike | 72.50 |
Expire Date | 2024-06-21 |
Day's Range | 9.35 - 9.35 |
Contract Range | N/A |
Volume | |
Open Interest | 174 |
Gilead (GILD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The pharmaceutical company is a leader in the global HIV drugs market
FOSTER CITY, Calif. / ACCESSWIRE / December 6, 2023 / Gilead Sciences, Inc. (NASDAQ:GILD) announced it will present new data at San Antonio Breast Cancer Symposium (SABCS) 2023, supporting the use of Trodelvy® (sacituzumab govitecan-hziy) in certain ...